A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1

Histone deacetylase (HDAC) inhibitors are considered novel agents for cancer chemotherapy. We previously investigated MHY219, a new HDAC inhibitor, and its potent anticancer activity in human prostate cancer cells. In the present study, we evaluated MHY219 molecular mechanisms involved in the regula...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomol Ther (Seoul)
Main Authors: De, Umasankar, Kundu, Soma, Patra, Nabanita, Ahn, Mee Young, Ahn, Ji Hae, Son, Ji Yeon, Yoon, Jung Hyun, Moon, Hyung Ryoung, Lee, Byung Mu, Kim, Hyung Sik
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Society of Applied Pharmacology 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4556203/
https://ncbi.nlm.nih.gov/pubmed/26336583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4062/biomolther.2015.026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados